Search - tctmd.com

Displaying 121 - 129 of 129

Sort: Relevancy | Date

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

February 17, 2017

DESolve Bioresorbable Stent Compares Well With Absorb but Longer Follow-up Needed

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

Bioresorbable Scaffolds is a Real Need:CONTRA

Presentation JIM 2017

Bioresorbable Scaffolds is a Real Need:CONTRA

Presenter: Robert A. Byrne

February 10, 2017

Bioresorbable Scaffolds: A Real Clinical Need? Yes!

Presentation JIM 2017

Bioresorbable Scaffolds: A Real Clinical Need? Yes!

Presenter: Gregg W. Stone

February 10, 2017

Bioresorbable Scaffolds: An Important Clinical Need

Presentation JIM 2017

Bioresorbable Scaffolds: An Important Clinical Need

Presenter: Gregg W. Stone

February 08, 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

February 07, 2017

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

TWENTE: Resolute and Xience Stents Show Comparable Outcomes Up to 5 Years

News Daily News

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Michael O'Riordan

January 20, 2017

Presentation

Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD

Presenter: Jens Wiebe

February 16, 0017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.